| Dr Scott Elliott Blattman, MD | |
|
6101 Woodway Dr, Ste 200, Woodway, TX 76712-6111 | |
| (254) 537-6300 | |
| (254) 537-6301 |
| Full Name | Dr Scott Elliott Blattman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 6101 Woodway Dr, Woodway, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023082146 | NPI | - | NPPES |
| 124785004 | Medicaid | TX | |
| 88X540 | Other | TX | BCBS |
| 00N59X | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | J1879 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bluebonnet Health Services Of Waco | Waco, TX | Home health agency |
| Providence Health Center | Waco, TX | Hospital |
| Baylor Scott & White Medical Center Hillcrest | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health Alliance | 6305731068 | 129 |
News Archive
Today, the American Society of Anesthesiologists announced their participation in a government-led effort to address the opioid epidemic, part of ASA's continued focus on patient safety and ongoing work to promote the safe use of prescription opioids. ASA is joined by a number of public and private sector partners in the efforts, which are being announced today by President Obama in Charleston, West Virginia.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
These donor physicians have also become more generous, and the shift of these medical professionals from their historic preference for Republican candidates to their recent affinity for Democrats is attributed to the increase in women doctors and the decline in the number who run their own practice or work in small practices.
Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government's 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center's Project on Emerging Nanotechnologies.
› Verified 9 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
Today, the American Society of Anesthesiologists announced their participation in a government-led effort to address the opioid epidemic, part of ASA's continued focus on patient safety and ongoing work to promote the safe use of prescription opioids. ASA is joined by a number of public and private sector partners in the efforts, which are being announced today by President Obama in Charleston, West Virginia.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
These donor physicians have also become more generous, and the shift of these medical professionals from their historic preference for Republican candidates to their recent affinity for Democrats is attributed to the increase in women doctors and the decline in the number who run their own practice or work in small practices.
Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government's 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center's Project on Emerging Nanotechnologies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Elliott Blattman, MD Po Box 18962, Belfast, ME 04915-4084 Ph: (800) 566-5050 | Dr Scott Elliott Blattman, MD 6101 Woodway Dr, Ste 200, Woodway, TX 76712-6111 Ph: (254) 537-6300 |
News Archive
Today, the American Society of Anesthesiologists announced their participation in a government-led effort to address the opioid epidemic, part of ASA's continued focus on patient safety and ongoing work to promote the safe use of prescription opioids. ASA is joined by a number of public and private sector partners in the efforts, which are being announced today by President Obama in Charleston, West Virginia.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
These donor physicians have also become more generous, and the shift of these medical professionals from their historic preference for Republican candidates to their recent affinity for Democrats is attributed to the increase in women doctors and the decline in the number who run their own practice or work in small practices.
Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government's 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center's Project on Emerging Nanotechnologies.
› Verified 9 days ago
Stefan Reid Huber, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9111 Jordan Lane, Suite 300, Woodway, TX 76712 Phone: 254-253-2855 Fax: 254-294-8413 | |
Dr. Todd Eric Blattman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6101 Woodway Dr, Ste 200, Woodway, TX 76712 Phone: 254-537-6300 Fax: 254-537-6301 | |
Natalie Lippe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6101 Woodway Dr, Ste 200, Woodway, TX 76712 Phone: 254-537-6300 Fax: 254-537-6301 |